DAYANG BIOTECH: In the first half of the year, the net profit attributable to the parent company was 50.5056 million yuan, a year-on-year increase of 60.66%

On August 25th, DAYANG BIOTECH disclosed its semi-annual report, stating that the company achieved operating revenue of 499 million yuan in the first half of the year, a year-on-year increase of 14.20%; the net profit attributable to shareholders of the listed company was 50.5056 million yuan, compared to 31.4363 million yuan in the same period last year, a year-on-year increase of 60.66%; basic earnings per share were 0.6212 yuan